News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Myeloma Paper of the Day, February 20th, suggested by Robert Orlowski
Feb 20, 2025, 10:33

Myeloma Paper of the Day, February 20th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Clonal plasma cell proportion in the synthetic phase calculated by analyzing DNA content between G0/G1 and G2/M identifies a unique high-risk cohort in myeloma and appears to be an independent prognostic marker.”

“Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma”

Authors: Saurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, Vincent Rajkumar, Shaji Kumar et al.

Myeloma Paper of the Day, February 20th, suggested by Robert Orlowski

More posts featuring Robert Orlowski.

cancer Dragan Jevremovic Myeloma Paper of the Day OncoDaily Oncology Prashant Kapoor Robert Orlowski Saurabh Zanwar Shaji Kumar Vincent Rajkumar
Special Coverage
Blog
Feb 21, 2025, 08:19
Chibuike Okafor: How Amgen Defeated the ‘Undruggable’ KRAS
Insight
Feb 21, 2025, 06:20
Gustavo Viani: New Evidence on Elective CTV in Early Anal Cancer
Blog
Feb 21, 2025, 06:10
Afreen Shariff: Start-ups are about persistence, grit and being comfortable with being uncomfortable
Radiotherapy
Feb 21, 2025, 04:51
Radiotherapy For Breast Cancer: Types, Success Rate, Side Effects And More
Library
Feb 20, 2025, 16:36
New Paper Alert: Systemic management of advanced HCC: an increasingly complex game
Blog
Feb 20, 2025, 14:43
MD Anderson Cancer Center and Texas Children's Hospital announced a collaboration dedicated solely to pediatric cancer care
Blog
Feb 20, 2025, 11:21
Thor Halfdanarson: Should Liver resection in patients with high-grade neuroendocrine neoplasms be considered?
Blog
Feb 20, 2025, 11:19
Jill Feldman: My Guiding Compass in Advocacy
Blog
Feb 20, 2025, 11:13
Abstract submissions are open for the ESMO Gynae25
Blog
Feb 20, 2025, 11:08
Aleix Prat: In ten years we will cure 80% of cancers
Blog
Feb 20, 2025, 11:00
Akshaya Keerti: PCOS and the Hidden Risk of Endometrial Cancer
Blog
Feb 20, 2025, 10:53
Fumiko Ladd Chino: Optimizing the EHR for patient-centered communication and care